The function of Golgi apparatus in LRRK2-associated Parkinson's disease

被引:4
|
作者
Wei, Yonghang [1 ]
Awan, Maher un Nisa [1 ]
Bai, Liping [1 ]
Bai, Jie [1 ]
机构
[1] Kunming Univ Sci & Technol, Med Sch, Lab Mol Neurobiol, Kunming, Peoples R China
来源
FRONTIERS IN MOLECULAR NEUROSCIENCE | 2023年 / 16卷
基金
中国国家自然科学基金;
关键词
Parkinson's; LRRK2; Rab29; VPS52; PKC; Golgi apparatus; ANIMAL-MODELS; LRRK2; KINASE; FRAGMENTATION; PROTEINS; PHOSPHORYLATION; TRAFFICKING; RAB; MUTATIONS; TRANSPORT;
D O I
10.3389/fnmol.2023.1097633
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a chronic neurodegenerative disease associated with the intracellular organelles. Leucine-rich repeat kinase 2 (LRRK2) is a large multi-structural domain protein, and mutation in LRRK2 is associated with PD. LRRK2 regulates intracellular vesicle transport and function of organelles, including Golgi and lysosome. LRRK2 phosphorylates a group of Rab GTPases, including Rab29, Rab8, and Rab10. Rab29 acts in a common pathway with LRRK2. Rab29 has been shown to recruit LRRK2 to the Golgi complex (GC) to stimulate LRRK2 activity and alter the Golgi apparatus (GA). Interaction between LRRK2 and Vacuolar protein sorting protein 52 (VPS52), a subunit of the Golgi-associated retrograde protein (GARP) complex, mediates the function of intracellular soma trans-Golgi network (TGN) transport. VPS52 also interacts with Rab29. Knockdown of VPS52 leads to the loss of LRRK2/Rab29 transported to the TGN. Rab29, LRRK2, and VPS52 work together to regulate functions of the GA, which is associated with PD. We highlight recent advances in the roles of LRRK2, Rabs, VPS52, and other molecules, such as Cyclin-dependent kinase 5 (CDK5) and protein kinase C (PKC) in the GA, and discuss their possible association with the pathological mechanisms of PD.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Clinical features of LRRK2-associated Parkinson's disease
    Pchelina, S. N.
    Ivanova, O. N.
    Emelyanov, A. K.
    Yakimovskii, A. F.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (12) : 56 - 62
  • [2] Progression and treatment of a series of patients with advanced LRRK2-associated Parkinson's disease
    Fernandez-Pajarin, G.
    Sesar, A.
    Jimenez-Martin, I.
    Castro, B.
    Castro, A.
    NEUROLOGIA, 2023, 38 (05): : 350 - 356
  • [3] Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
    Rudenko, Iakov N.
    Chia, Ruth
    Cookson, Mark R.
    BMC MEDICINE, 2012, 10
  • [4] Parkinson's disease-associated mutant LRRK2 phosphorylates Rab7L1 and modifies trans-Golgi morphology
    Fujimoto, Tetta
    Kuwahara, Tomoki
    Eguchi, Tomoya
    Sakurai, Maria
    Komori, Tadayuki
    Iwatsubo, Takeshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (02) : 1708 - 1715
  • [5] Function of LRRK2 in Parkinson's Disease
    Zhu Fei-Zhou
    Xia Kun
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2010, 37 (10) : 1059 - 1066
  • [6] LRRK2 and membrane trafficking: nexus of Parkinson's disease
    Hur, Eun-Mi
    Jang, Eun-Hae
    Jeong, Ga Ram
    Lee, Byoung Dae
    BMB REPORTS, 2019, 52 (09) : 533 - 539
  • [7] Nanobodies as allosteric modulators of Parkinson's disease-associated LRRK2
    Singh, Ranjan K.
    Soliman, Ahmed
    Guaitoli, Giambattista
    Stoermer, Eliza
    von Zweydorf, Felix
    Dal Maso, Thomas
    Oun, Asmaa
    Van Rillaer, Laura
    Schmidt, Sven H.
    Chatterjee, Deep
    David, Joshua A.
    Pardon, Els
    Schwartz, Thomas U.
    Knapp, Stefan
    Kennedy, Eileen J.
    Steyaert, Jan
    Herberg, Friedrich W.
    Kortholt, Arjan
    Gloeckner, Christian Johannes
    Versees, Wim
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (09)
  • [8] LRRK2 activation in idiopathic Parkinson's disease
    Di Maio, Roberto
    Hoffman, Eric K.
    Rocha, Emily M.
    Keeney, Matthew T.
    Sanders, Laurie H.
    De Miranda, Briana R.
    Zharikov, Alevtina
    Van Laar, Amber
    Stepan, Antonia F.
    Lanz, Thomas A.
    Kofler, Julia K.
    Burton, Edward A.
    Alessi, Dario R.
    Hastings, Teresa G.
    Greenamyre, J. Timothy
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (451)
  • [9] Roco Proteins and the Parkinson's Disease-Associated LRRK2
    Liao, Jingling
    Hoang, Quyen Q.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (12)
  • [10] LRRK2 in Parkinson's disease: function in cells and neurodegeneration
    Webber, Philip J.
    West, Andrew B.
    FEBS JOURNAL, 2009, 276 (22) : 6436 - 6444